Details for New Drug Application (NDA): 084015
✉ Email this page to a colleague
NDA 084015 describes BLEPH-10, which is a drug marketed by Allergan and is included in two NDAs. Additional details are available on the BLEPH-10 profile page.
The generic ingredient in BLEPH-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
The generic ingredient in BLEPH-10 is sulfacetamide sodium. There are three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sulfacetamide sodium profile page.
Summary for 084015
| Tradename: | BLEPH-10 |
| Applicant: | Allergan |
| Ingredient: | sulfacetamide sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084015
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;OPHTHALMIC | Strength | 10% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
